Peterborough

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)2 trials

Phase

• Phase 31 trial

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Regeneron Pharmaceuticals2 trials

Running trials

• Active, not recruiting

  Study of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD)

  NCT03428646· Regeneron Pharmaceuticals· Source

Closed trials

• Completed

  Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)

  NCT02612454· Phase 3· Regeneron Pharmaceuticals· Source